| Sarah Trusewicz, MOT | |
|
1424 S Main St Ste 2, Adrian, MI 49221-4309 | |
| (616) 935-3300 | |
| Not Available |
| Full Name | Sarah Trusewicz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1424 S Main St Ste 2, Adrian, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881472413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5201013652 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Trusewicz, MOT 1311 Mamaroneck Ave Ste 140, White Plains, NY 10605-5224 Ph: (914) 294-4050 | Sarah Trusewicz, MOT 1424 S Main St Ste 2, Adrian, MI 49221-4309 Ph: (616) 935-3300 |
News Archive
The European Society of Cardiology (ESC) welcomes the spotlight that a US study has placed on the importance of measuring rates of rehospitalisation following percutaneous coronary intervention (PCI) procedures.
Thirteen years of waiting is now over for melanoma patients. That's how long it's been since the last therapy became available to treat the most lethal form of skin cancer – melanoma. The FDA today announced approval of Yervoy, an immunotherapy treatment for advanced melanoma.
Researchers from Loyola University Chicago Stritch School of Medicine have developed a technology that improves the detection of tumors during radiation therapy for early-stage lung cancer.
Modern Healthcare reports that May 1 is the deadline for insurers to apply to offer heatlh plans for sale on state-run exchanges. However, the deadline for participation in states that have opted for federally run exchanges has been extended until Friday.
A recent report published in Science Translational Medicine by MUSC Hollings Cancer Center investigator Sophie Paczesny, M.D., Ph.D., sheds light on immune cell biomarkers that may reveal which patients are most at risk for graft-versus-host disease (GVHD), a life-threatening condition that can arise after hematopoietic stem cell transplantation (HSCT) for treatment of liquid cancers such as leukemia.
› Verified 5 days ago
Tiffany Keith, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Kimole Ln, Adrian, MI 49221 Phone: 517-263-6771 | |
Laura M Ernst, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1200 Corporate Dr, Adrian, MI 49221 Phone: 517-264-2790 | |
Jason Higgins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Riverside Ave, Adrian, MI 49221 Phone: 517-266-1700 | |
Lisa Ritz, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1800 W Us Highway 223, Adrian, MI 49221 Phone: 517-263-3378 Fax: 517-263-4527 | |
Kassidy Lyn Roe, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Sand Creek Hwy, Adrian, MI 49221 Phone: 517-263-6794 | |
Stephanie Olszewski, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1424 S Main St, Adrian, MI 49221 Phone: 517-312-1712 Fax: 517-312-1711 | |
Ms. Lori A Scouten, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Riverside Ave, Adrian, MI 49221 Phone: 517-266-1700 |